ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HYPR vs VANI // ALTMAN Z-SCORE & DEBT/EQUITY

Hyperfine Inc. (Class A) (NASDAQ) VS. Vivani Medical Inc. (NASDAQ) • 15-METRIC TALLY: HYPR 1 — VANI 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HYPR VS. VANI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HYPR VANI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -24.79% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 5.20% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 HYPR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.6 45.0 -2.40 VANI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 3.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $78.9M $102.8M -$24.0M VANI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HYPR REV VANI REV HYPR GROSS % VANI GROSS % HYPR FCF VANI FCF
FY 2025 $13.6M $0 49.8% — -$29.1M -$25.5M
FY 2024 $12.9M $0 45.7% — -$39.1M -$21.3M
FY 2023 $11.0M $0 — — -$41.8M -$23.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HYPR // BETA —
VANI // BETA —